Efficacy News and Research

RSS

New guidelines on non-muscle invasive bladder cancer

The AUA is pleased to announce their new Guideline on the Management of Nonmuscle Invasive Bladder Cancer. Each year, more than 60,000 people are diagnosed with bladder cancer, which has been linked to a number of risk factors, including cigarette smoking and exposure to hazardous chemicals.

13 Nov 2007

Potential block buster on the horizon - new vaccine to control high blood pressure

A vaccine that would help people control their blood pressure is showing promise in early trials.

7 Nov 2007

D-cycloserine could help treat drug addiction

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory provide further evidence that a drug known as D-cycloserine could play a role in helping to extinguish the craving behaviors associated with drug addiction.

6 Nov 2007

Bavarian Nordic updates on vaccine project pipeline

In a business update, Danish-based biopharmaceutical company Bavarian Nordic, reported a number of developments in its vaccine project pipeline.

6 Nov 2007

Antibiotic that appears to control phobias may also be useful in treating addiction

6 Nov 2007

Zambia Medical Association calls for collaboration on HIV/AIDS research between doctors, herbalists

Conventional doctors and traditional herbalists in Zambia must collaborate on quality research for potential HIV/AIDS treatments to help reduce the spread of HIV/AIDS in the country, Zambia Medical Association President Swebby Macha said recently, Xinhua News Agency reports.

6 Nov 2007

Stereotaxis announces first atrial fibrillation procedures performed with performed with magnetic irrigated catheter

Stereotaxis, Inc. has announced that the first atrial fibrillation procedures performed with its partnered magnetic irrigated catheter were successfully completed over the course of the past week.

6 Nov 2007

New strategy for translational research creates new arrangements for clinical trials

The Medical Research Council (MRC) and the National Institute for Health Research (NIHR) have announced a new joint arrangement for clinical trials. The initiative forms a key part of the developing MRC- NIHR joint strategy for translational research.

5 Nov 2007

New investigational combination pill improves multiple cholesterol disorders

Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented at the American Heart Association's Scientific Sessions.

5 Nov 2007

Antibody might help starve cancerous tumors

An antibody might offer a safe and effective complement to anti-cancer therapies designed to starve malignant tumors by pruning the blood vessels that feed them, researchers report in the November 2 issue of the journal Cell, a publication of Cell Press.

2 Nov 2007

Studies attribute recent increase in multiple myeloma survival to novel therapies

Multiple myeloma is one of the most common and devastating bone marrow cancers in the U.S., but survival rates have risen dramatically over the past decade.

2 Nov 2007

Enzyme sphingosine kinase 2 show to be potential new target to fight cancer

Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.

2 Nov 2007

Bevacizumab improves ovarian cancer treatment

A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.

1 Nov 2007

Research programme for foods and services promoting well-being

One of the challenges facing the food industry is how to create tasty, convenient and experiential products made from health promoting ingredients.

31 Oct 2007

Lithium commonly used to treat bi-polar disorder increases lifespan in Nematode worms

Nematode worms treated with lithium show a 46 percent increase in lifespan, raising the tantalizing question of whether humans taking the mood affecting drug are also taking an anti-aging medication.

31 Oct 2007

Lessons learned from Marburg and Ebola outbreaks

Outbreaks of filovirus haemorrhagic fevers (FHFs) such as those caused by the Ebola and Marburg viruses can only be controlled if agencies have the support and trust of local communities, according to two papers just published in the online edition of the Journal of Infectious Diseases as part of a special supplement on filovirusues.

29 Oct 2007

Quality-of-life yardstick needed for children with serious urologic conditions

A small but revealing study from the Johns Hopkins Children's Center suggests that a widely used tool to measure physical, emotional and psychological functioning and well-being in children may fail to accurately gauge these quality-of-life indicators in the children with some of the most severe bladder conditions, such as spina bifida and bladder exstrophies.

28 Oct 2007

Shire announces data from a 12-month study of Daytrana for ADHD

Shire plc has announced that data from a 12-month study of DAYTRANATM (methylphenidate transdermal system), the Attention Deficit Hyperactivity Disorder (ADHD) patch, demonstrated that DAYTRANA provided significant ADHD tolerability and symptom control improvement in children aged 6 to 12 years.

28 Oct 2007

Emerging cancer therapies and novel targets

What are the cancer drugs of tomorrow and how will they be developed? At the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, researchers will present some answers to these and other pressing questions regarding emerging cancer therapeutics.

25 Oct 2007

Blood markers can help choose best dose for antiangiogenic drugs

Scientists at Sunnybrook have new information that may help to improve the use of anti-cancer drugs designed to block the growth of new blood vessels in tumors, a process called angiogenesis that is critical to tumor growth.

25 Oct 2007